Skip to content

Annagiulia Di Trana

5 papers in the library · 74 citations · publishing 2020-2026

Papers

Sort Most recent Most cited

Pharmacokinetic disposition in oral fluid, excretion profile, and subjective and physiological responses following oral and intranasal administration of Clophedrone (3-CMC)

October 13, 2026 Nunzia La Maida, Lourdes Poyatos, Annagiulia Di Trana et al.

Background and Purpose: Clophedrone (3-chloromethcathinone, 3-CMC) belongs to the methcathinone subclass of ring-substituted cathinones, a prominent group of new psychoactive substances (NPS) present in the illicit drug market. To date no studies have assessed concentrations and acute effects of 3-CMC in humans after self-administration. Experimental Approach: A total of 16 psychostimulant...

Acute pharmacological effects of α-PVP in humans: a naturalistic observational study.

Frontiers in Pharmacology 2025 Georgina de la Rosa, Esther Papaseit, Olga Hladun et al. 7 citations

Alpha-pyrrolidinopentiophenone (α-PVP) is a commonly consumed analogue of pyrovalerone, a synthetic cathinone with psychostimulant properties similar to those of 3,4-Methylenedioxypyrovalerone (MDPV) and cocaine. Since the pharmacology of α-PVP remains scarcely studied, we aimed to evaluate the acute pharmacological effects and its abuse potential in humans after intranasal administration. We...

DOI: 10.3389/fphar.2025.1626692 (opens in new tab) Full text (opens in new tab) Cathinones New psychoactive substances Alpha-pyrrolidinopentiophenone α-pvp α-pvp Synthetic cathinone +12

New Psychoactive Substances Toxicity: A Systematic Review of Acute and Chronic Psychiatric Effects.

International Journal of Molecular Sciences August 31, 2024 Beldisa Taflaj, Nunzia La Maida, Roberta Tittarelli et al. 22 citations

New psychoactive substances (NPSs) are a heterogenous group of psychotropic molecules and diverted pharmaceutical drugs sold worldwide as legal substitutes for controlled drugs. The psychiatric consequences of NPS use are relatively unknown, although evidence of related psychotic symptoms has been described in the literature. We sought to summarize the available evidence on NPS-related...

DOI: 10.3390/ijms25179484 (opens in new tab) Full text (opens in new tab) Bipolar disorder Hallucinations Mental disorders New psychoactive substances +4

Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance.

Current Neuropharmacology 2023 Silvia Graziano, Maria Rosaria Varì, Simona Pichini et al.

During the last two years, hexahydrocannabinol (HHC), the hydrogenated derivative of tetrahydrocannabinol has been freely sold by internet websites as a "legal" replacement to THC and cannabis in a range of highly attractive branded and unbranded products, some of which are sold as "legal highs". Potentially, there could be a large demand for HHC products by individuals in Europe and...

DOI: 10.2174/1570159x21666230623104624 (opens in new tab) Full text (opens in new tab) Hexahydrocannabinol New psychoactive substances Phytocannabinoids Synthetic cannabinoids

Biomedical analysis of New Psychoactive Substances (NPS) of natural origin.

Journal of Pharmaceutical and Biomedical Analysis February 5, 2020 Alfredo Fabrizio Lo Faro, Annagiulia Di Trana, Nunzia La Maida et al. 45 citations

New psychoactive substances (NPS) can be divided into two main groups: synthetic molecules and active principles of natural origin. With respect to this latter group, a wide range of alkaloids contained in plants, mainly from Asia and South America, can be included in the class of NPS of natural origin. The majority NPS of natural origin presents stimulant and/or hallucinogenic effects (e.g....

DOI: 10.1016/j.jpba.2019.112945 (opens in new tab) Full text (opens in new tab) Alkaloids Biomedical analysis Plants Natural psychoactive substances +1